Abstract
An efficient and environmentally benign diversity oriented synthetic protocol has been presented for the synthesis of structurally diverse spiroquinazolines. The hybrid druglike molecules incorporating medicinally privileged heterocyclic systems (spiroquinazolinespirooxindoles) have been synthesized by three-component reaction of isatoic anhydride, aromatic amines and substituted isatins using gluconic acid aqueous solution (GAAS, 50%, wt%) as an efficient, inexpensive and eco-friendly bio-based catalytic solvent system.
Keywords: Diversity oriented synthesis, environmentally benign synthetic protocol, spiroquinazoline-spirooxindoles, gluconic acid aqueous solution (GAAS, 50%, wt%).
Current Catalysis
Title:An Efficient and Environmentally Benign One-pot Three- Component Domino Protocol for the Synthesis of Structurally Diverse Spiroquinazolines
Volume: 4 Issue: 3
Author(s): Sarita Khandelwal, Anshu Rajawat and Mahendra Kumar
Affiliation:
Keywords: Diversity oriented synthesis, environmentally benign synthetic protocol, spiroquinazoline-spirooxindoles, gluconic acid aqueous solution (GAAS, 50%, wt%).
Abstract: An efficient and environmentally benign diversity oriented synthetic protocol has been presented for the synthesis of structurally diverse spiroquinazolines. The hybrid druglike molecules incorporating medicinally privileged heterocyclic systems (spiroquinazolinespirooxindoles) have been synthesized by three-component reaction of isatoic anhydride, aromatic amines and substituted isatins using gluconic acid aqueous solution (GAAS, 50%, wt%) as an efficient, inexpensive and eco-friendly bio-based catalytic solvent system.
Export Options
About this article
Cite this article as:
Khandelwal Sarita, Rajawat Anshu and Kumar Mahendra, An Efficient and Environmentally Benign One-pot Three- Component Domino Protocol for the Synthesis of Structurally Diverse Spiroquinazolines, Current Catalysis 2015; 4 (3) . https://dx.doi.org/10.2174/2211544704666150508221522
DOI https://dx.doi.org/10.2174/2211544704666150508221522 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
Current Alzheimer Research Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Current Drug Targets Recent Findings Confirm LIM Domain Kinases as Emerging Target Candidates for Cancer Therapy
Current Cancer Drug Targets The Pandemic of Coronavirus Disease 2019 (COVID-19)
Current Molecular Medicine Allosterism at Muscarinic Receptors: Ligands and Mechanisms
Mini-Reviews in Medicinal Chemistry <i>Caralluma edulis</i> (Apocynaceae): A Comprehensive Review on its Traditional Uses, Phytochemical Profile and Pharmacological Effects
Current Topics in Medicinal Chemistry New Methodologies for Ligand-Based Virtual Screening
Current Pharmaceutical Design Graphical Abstracts
Medicinal Chemistry Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets
Current Pharmaceutical Design Benzothiazoles: How Relevant in Cancer Drug Design Strategy?
Anti-Cancer Agents in Medicinal Chemistry The Orvinols and Related Opioids - High Affinity Ligands with Diverse Efficacy Profiles
Current Pharmaceutical Design Prevention, Diagnosis and Treatment of COVID-19: A Nanotechnological Perspective
Current Nanoscience A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19
Infectious Disorders - Drug Targets Optimizing Ventilation with the Open Lung Maneuver
Current Respiratory Medicine Reviews 3D QSAR Pharmacophore, CoMFA and CoMSIA Based Design and Docking Studies on Phenyl Alkyl Ketones as Inhibitors of Phosphodiesterase 4
Medicinal Chemistry AMPA Receptor Antagonists
Current Medicinal Chemistry Drug Targets for Rational Design against Emerging Coronaviruses
Infectious Disorders - Drug Targets Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Current Pharmaceutical Design Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer’s Disease?
Current Alzheimer Research Virtual Screening An Effective Tool for Lead Structure Discovery
Current Pharmaceutical Design